Blog
Articles, analyses, and updates on the American pharmaceutical market, medication access, and what's changed in the regulatory environment.
High-cost American medications — oncology, rare-disease, and biologic therapies — rarely fail on the science. They fail on the chain: sourcing at the origin,…
Read more →Topics we cover
New FDA approvals, advances in immunotherapy, and access to cutting-edge chemotherapy
New orphan drugs, access challenges, and compassionate use cases
The biologics market in the US, differences between biologics and biosimilars, price trends
Regulation, pricing, health policies, and what impacts medication availability
Import processes, country-specific requirements, practical cases, and compliance in the international chain
The content on Tideon Pharma's blog is for informational purposes only. It does not constitute medical, legal, or regulatory advice. Always consult qualified professionals before making decisions related to medical treatments or medication importation.